Results indicated that, overall, the ACCU-CHEK Aviva and ACCU-CHEK Compact Plus blood glucose monitoring systems and the ACCU-CHEK Multiclix, ACCU-CHEK Softclix and ACCU-CHEK Softclix Plus lancing devices were least painful when compared to competitors. Those competitors were:
System Lancing Device Ascensia(R) Contour(R) Microlet(R)/Vaculance(R) Freestyle Freedom(R) TheraSense(R) Freestyle(R) OneTouch(R) Ultra(R)2 LifeScan UltraSoft(R)
"We are pleased a recent study confirms that our products are perceived as
least painful for all three testing sites included in the study-finger, palm
and forearm," said Roche Director of Product Marketing
Aspy added that this vibration, which occurs with conventional technology, causes side-to-side motion. This motion coupled with the lancet stopping abruptly and then bouncing back result in painful tissue damage. The technology used in the ACCU-CHEK products works in an entirely different way to greatly reduce this painful damage. ACCU-CHEK lancing devices also offer 11 depth settings, so patients can find a lancing depth to match their skin type. This customized depth penetration avoids painful nerve endings. And high-quality ACCU-CHEK lancets use comfortable, thin 28- and 30-gauge lancets with beveled tips. Lower-quality lancets use larger needles, and many lack the beveled tips, causing skin trauma.
The study consisted of 165 subjects who tested at home at least 3 times a day for 36 days, testing on each site-finger, palm and forearm-with each of the 3 competitor brands and 1 of the ACCU-CHEK products. After testing was completed, responses by subjects to the products were compared. In a second experiment in a laboratory setting, the ACCU-CHEK Multiclix and ACCU-CHEK Softclix Plus lancing devices were compared individually to competitor lancing devices.
"There is no question that better management of diabetes results in better outcomes for the patient," Aspy said. "By offering a lancing device that results in least painful testing, we are helping to remove one of the barriers to adequate testing for improved diabetes management."
The comparative pain study was conducted by Dr.
About Roche Diabetes Care
Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committed to helping people with diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients' condition in an optimal way. Today, the ACCU-CHEK portfolio offers people with diabetes and healthcare professionals innovative products, services and comprehensive solutions for convenient, efficient and effective diabetes management-from blood glucose monitoring through information management to insulin delivery. The ACCU-CHEK brand encompasses blood glucose meters, infusion pumps, lancing and data management systems.
For more information, please visit accu-chek.com.
For further information, please contact: Julie Vincent Public Relations Consultant Roche email@example.com 317-521-1910
SOURCE Roche Diabetes Care